Zhi Tong Cai Jing·2025-08-29 14:36Core Viewpoint - Spring Medical (01858) reported a significant increase in both revenue and net profit for the first half of 2025, indicating strong operational performance and market expansion efforts [1] Financial Performance - The company's revenue reached approximately 488 million yuan, representing a year-on-year growth of 28.27% [1] - Net profit attributable to shareholders was about 114 million yuan, showing a year-on-year increase of 44.85% [1] - Basic earnings per share stood at 0.3 yuan [1] Revenue Growth Drivers - Revenue growth was primarily driven by stable supply of centralized procurement products and continuous increase in sales volume during the reporting period [1] - The company has been steadily advancing its international market expansion, leading to a rise in export business [1] Profitability Improvement - The increase in net profit was attributed to stable supply of centralized procurement products and deepening international market expansion, which boosted sales [1] - Internal cost reduction and efficiency enhancement measures were implemented to strengthen core business competitiveness, contributing to steady improvement in profitability [1]